Cytokine-induced killer (CIK) cell therapy for patients with hepatocellular carcinoma: efficacy and safety

PURPOSE: To evaluate the efficacy of cytokine-induced killer (CIK) cell therapy in the treatment of hepatocellular carcinoma. MATERIALS AND METHODS: Randomized phase II and III trials on CIK cell-based therapy were identified by electronic searches using a combination of "hepatocellular carcino...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Ma, Yue, Xu, Ying-Chun, Tang, Lei, Zhang, Zan, Wang, Jian, Wang, Hong-Xia
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2012
Konular:
Methodology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3514101/
https://ncbi.nlm.nih.gov/pubmed/23210562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2162-3619-1-11
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller